Bioscan licenses IDSI molecular imaging technology

By staff writers

September 5, 2006 -- CT laser mammography (CTLM) developer Imaging Diagnostic Systems (IDSI) has licensed its laser optical imaging technology to molecular imaging developer Bioscan of Washington, DC.

The Plantation, FL-based IDSI said that it granted Bioscan an exclusive worldwide license to manufacture and distribute optical imaging equipment incorporating its Laser Imager for Lab Animals (LILA) technology.

Under terms of the agreement, Bioscan will pay an up-front license fee and royalty payments as the technologies are commercialized. IDSI will transfer its small animal optical computed tomography (CT) technology, including licensing 10 issued U.S. patents, and three pending patents for optical CT imaging.

By staff writers
September 5, 2006

IDSI gets Colombian sale, August 8, 2006

IDSI adds second Czech order, August 1, 2006

IDSI adds third Polish sale, June 13, 2006

Bioscan displays NanoSPECT/CT animal imager, June 7, 2006

IDSI begins clinical trials, May 1, 2006

Copyright © 2006


To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking